What sector does Entero Healthcare Solu L belong to?

Entero Healthcare Solu L operates in the Consumer Discretionary sector, specifically the Pharmacy Retail industry, and is listed on the NSE.

What is the current share price of ENTERO?

As of the latest available quote, ENTERO traded at ₹1,815.40. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of ENTERO?

Entero Healthcare Solu L has a price-to-earnings (P/E) ratio of about 62.90. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of ENTERO?

The market capitalisation of Entero Healthcare Solu L is approximately ₹7,901 Cr.

Is Entero Healthcare Solu L profitable?

For its latest reported financial year, Entero Healthcare Solu L recorded a net profit margin of about 2.22%.

Does ENTERO pay a dividend?

Entero Healthcare Solu L does not currently show a dividend yield in our data.

What is the return on equity (ROE) of ENTERO?

Entero Healthcare Solu L has a return on equity (ROE) of about 6.94%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of ENTERO?

Over the past 52 weeks, ENTERO has traded between a low of ₹944.00 and a high of ₹1,920.00.

Entero Healthcare Solu L

ENTERO NSE Consumer Discretionary Pharmacy Retail

Microcap 250

₹1,815.40

+1.25%

Delayed · cached 15 min

Fair value analysis

ENTERO

Entero Healthcare Solu L

₹1,792.90

Close used for this calculation

₹866.86Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

26/100

Profitability4/25

Returns3/25

Balance Sheet17/25

Efficiency2/25

Growth0/25

Weak

Quality radar

Consensus fair value

₹866.86

Above FV

▼ -51.7% against the close used

Model range ₹123.34 – ₹1,307.46

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹123.34Fair value₹866.86Bull₹1,307.46

FairClose

52-week traded range

52W low ₹949.2052W high ₹1,898.40

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Entero Healthcare Solu L closed at ₹1,792.90, 106.8% above the consensus fair value of ₹866.86 drawn from 7 valuation models.

Financial DNA score 26/100 — Weak. P/E of 61.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹123.34

-93.1%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₹505.75

-71.8%

√(22.5 × EPS × BVPS)

EPS=26.44, BVPS=429.95 · outside Graham range (P/E 61.2, P/B 4.2) — asset-light, treat as a rough floor

P/E Fair Value

₹1,307.46

-27.1%

EPS × 49.45x (sector P/E)

EPS=26.44, Sector P/E=49.45x

EV/EBITDA

₹547.56

-69.5%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=3.09B

Book Value (P/B)

₹242.00

-86.5%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=429.95, ROE=6.9%, g=3%, r=10%

Reverse DCF

₹1,792.90

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 23.7% | Historical: 0%

Margin of Safety

₹484.14

-73.0%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=645.52, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer